Table 3.
Antibacterial Resistance Leadership Group Engagement Opportunities
| Mentoring | Applications available at https://arlg.org/ |
|---|---|
| ARLG Fellowship | • Competitive award for post-doctoral fellows interested in pursuing research, training, and a subsequent career in patient-oriented research in antibacterial resistance • Salary for 2 years • Mentoring in antibacterial resistance research, tuition support for formal master’s degree training in clinical trials, and integration into the ARLG committee infrastructure • Trainee serves on the Steering Committee and Scientific Subcommittees of the ARLG • Fellows pursue a research project and receive formal instruction in quantitative and methodological principles of clinical research; applications for the ARLG fellowship are submitted online via the ARLG website using established ARLG forms |
| Early Stage Investigator seed grant | • Provides up to $50 000 in direct costs to support research in antibacterial resistance by MD, PhD, or PharmD students, graduate or post-graduate trainees, or individuals with a faculty appointment for ≤5 years |
| Trialist in Training | • For trainees able to commit to projects for longer than the usual 2 years of the ARLG fellowship • Candidates “embedded” in day-to-day operations of an ARLG clinical trial • Salary support to develop protocols and participate in clinical trials implementation and data management • Authorship on publications that result from the project |
| Outreach | |
| Campaigns | • Two Blood Stream Infection Task Force Surveys ◦ Raised awareness and drove traffic with newsletter items, website news, IDSA emails and message board posts, communications kits to ARLG members, Twitter • Fellowship campaign ◦ Updated fellowship website page (including new video and infographic); drove traffic with newsletter items, website news, IDSA emails and message board posts, communications kits to ARLG members, Twitter, promotional toolkits for stakeholders (included banner ads, Twitter and LinkedIn posts, infographic, ID Colleague email, news story, and video) • Gram-negative communication plan to solicit proposals ◦ Raised awareness and drove traffic with social media, email blasts, newsletter mentions, and news item on website • IDSA Outreach Campaign ◦ Solicited survey information on top research priorities to develop the ARLG scientific agenda |
| • Access Twitter handle, @ARLGnetwork | |
| Other | Information available at https://arlg.org/ |
| Contact ARLG link | • Submit questions and comments directly to the ARLG |
| ARLG newsletter | • Subscribe to quarterly newsletter that highlights the progress of the ARLG scientific agenda and studies and members of the ARLG community |
| Clinical trial site | • Join the ARLG site network to be considered for current and future ARLG study participation |
| Data sharing | • Request datasets from ARLG studies |
| Virtual biorepository | • Access a web-based system that provides unique access to clinically well-characterized gram-positive and gram-negative bacteria for the development of diagnostic tests, novel antimicrobial compounds and for studies evaluating mechanisms of resistance |
| Physical biorepository | • Access clinically characterized isolates and clinical specimens from ARLG studies that are stored in a centralized facility and are available to the scientific community |
| Protocol concept | • Submit a protocol concept consistent with the ARLG’s 3 prioritized areas of research for funding |
| Industry collaboration | • Engage with subject matter experts and key opinion leaders in antibacterial resistance to inform research agendas and product/device development |
Abbreviations: ARLG, Antibacterial Resistance Leadership Group; ID, infectious disease; IDSA, Infectious Disease Society of America.